Navigation Links
QIAGEN and Max Planck Institute for Infection Biology Collaborate to Develop Assay for Active TB Risk in Individuals With Latent Infection
Date:1/9/2012

Tools for rapid diagnosis, prevention and therapy are urgently needed to sustainably reduce the global risk. The WHO has set up a strategic program to dramatically reduce the global burden of TB by 2015, for example, by supporting the development of new tools and enabling their timely and effective use.

* WHO: 2011/2012 Tuberculosis Global Facts (http://www.who.int/tb/publications/2011/factsheet_tb_2011.pdf)

About Max Planck Institute for Infection Biology:

The MPIIB was founded in 1993. The Institute commenced operation in a provisional laboratory facility with a small group of scientists, greatly expanded over the years, and relocated to a dedicated facility in summer 2000. It is located in the heart of Berlin on the historical Charité medical campus, where Robert Koch, Paul Ehrlich and Emil Behring made their important discoveries, pioneering the field of infection research, in close proximity to the German Parliament and the newly constructed government offices. The choice of location was intended to support the goal of the Institute to research infectious diseases in close collaboration with universities and clinical units. Further information about the MPIIB can be found at http://www.mpiib-berlin.mpg.de/home.html.

About QIAGEN:

QIAGEN N.V., a Netherlands holding company, is the leading global provider of sample and assay technologies. Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue. Assay technologies are used to make these isolated biomolecules visible. QIAGEN has developed and markets more than 500 sample and assay products as well as automated solutions for such consumables. QIAGEN provides its products to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and appli
'/>"/>

SOURCE QIAGEN N.V.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. QIAGEN to Develop New Companion Diagnostic for Compound in Clinical Trials for Blood Cancers
2. QIAGEN and Abbott Enter Into Agreement on Molecular Tests for HIV, HCV and HPV
3. QIAGEN and Roche Settle Dispute Over Distribution Agreement for TheraScreen Companion Diagnostics
4. QIAGEN Acquires Comprehensive Portfolio of Molecular Food Safety Tests
5. QIAGEN Acquires Exclusive Licence for Key PI3K gene
6. QIAGENs New Product Line, QIAsafe(R) DNA Blood, has Been Co-Developed With Biomatrica and is Based on Biomatricas SampleMatrix(R) Technology
7. Webcast of QIAGEN N.V.s (Nasdaq: QGEN) Second Quarter 2009 Financial Results Call Set for August 11
8. Plexus Awarded Development Contract With QIAGEN
9. QIAGEN and Chittaranjan National Cancer Institute Partner to Establish First Large-Scale Cervical Cancer Screening Program in Kolkata
10. Webcast of QIAGEN N.V.s (Nasdaq: QGEN) Fourth Quarter and Year-End 2008 Financial Results Call Set for February 10
11. QIAGEN Welcomes 3,000th Employee in 20th year of U.S. Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... DTS Language Services, Inc . is pleased to ... Science organizations who need document translations. Clients will now ... documents in advance with a selection of nearly 50 life ... a critical factor in clinical and scientific fields, and decrease ...
(Date:1/14/2014)... Date: Friday, April 11, 2014 , Time: ... 1360 Almshouse Road, Warrington, Pa. , Details: The ... to finding a cure for hepatitis B and improving the ... annual Crystal Ball on Friday, April 11 at Warrington Country ...
(Date:1/14/2014)... January 14, 2014 EquitiesIQ, a leading ... (OTCQB: ALQA). Alliqua is an emerging biomedical company acquiring, ... wound care market. , Free report download: http://equitiesiq.com/reports/alliqua/ ... a seasoned management team and Board, which launched the ...
(Date:1/14/2014)... 2014  RXi Pharmaceuticals Corporation (OTCQX: RXII), a biotechnology ... therapies addressing major unmet medical needs using RNA-targeted ... of Allowance from the United States Patent and ... (sd-rxRNA®), for the treatment of fibrosis. The patent ...
Breaking Biology Technology:DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3
... 21 CV Therapeutics,Inc. (Nasdaq: CVTX ) announced ... for presentation at the American Heart,Association (AHA) Scientific Sessions ... November 8 - 12, 2008., In addition, company ... will present The Industry,s Perspective on the Pressures,Challenges and ...
... Postpones Special Meeting of Shareholders until further notice, RICHMOND, ... follow-on biologics and biopharmaceuticals, today,announced that on Thursday, October 16, ... Effective immediately, NASDAQ has suspended the enforcement of the rules ... bid price. -- Effective immediately, NASDAQ has also ...
... 21 Perceptive Informatics, the,industry,s leading eClinical technology ... PRXL ), today announced the,release of an ... (EDC) and Clinical Data Management System (CDMS) solution ... studies. The enhanced,4.3 version of the DataLabs EDC ...
Cached Biology Technology:CV Therapeutics Announces Presentations at American Heart Association Scientific Sessions 2008 2CV Therapeutics Announces Presentations at American Heart Association Scientific Sessions 2008 3Insmed Announces That NASDAQ Temporarily Suspends Minimum Bid Closing Price Rule 2Insmed Announces That NASDAQ Temporarily Suspends Minimum Bid Closing Price Rule 3Perceptive Informatics Improves Efficiency and Clinical Data Quality With Enhanced Version of EDC System 2Perceptive Informatics Improves Efficiency and Clinical Data Quality With Enhanced Version of EDC System 3Perceptive Informatics Improves Efficiency and Clinical Data Quality With Enhanced Version of EDC System 4Perceptive Informatics Improves Efficiency and Clinical Data Quality With Enhanced Version of EDC System 5Perceptive Informatics Improves Efficiency and Clinical Data Quality With Enhanced Version of EDC System 6
(Date:4/17/2014)... news release is available in German . ... us to recognise objects; they also provide us with a ... run, turn around, fall or sit still in a car ... motion trace on our retinas. Seemingly without effort, our brain ... maintain a stable position and a steady gaze during our ...
(Date:4/17/2014)... If a restaurant ... he can expect his premises to be trashed. Warnings like ... is enough to make restaurant owners pay up. Similarly, mafia-like ... in other birds, nests. If the host birds throw the ... destroying the entire nest. Consequently, it is beneficial for hosts ...
(Date:4/17/2014)... recent Yokahama IPCC meeting painted a stark warning on ... which has a greenhouse effect 32 times that of ... shown that humic substances act as fully regenerable electron ... are held in wetlands instead of being released to ... system is disrupted it may enter into a vicious ...
Breaking Biology News(10 mins):How vision makes sure that little fish do not get carried away 2How vision makes sure that little fish do not get carried away 3How vision makes sure that little fish do not get carried away 4Fear of the cuckoo mafia 2Fear of the cuckoo mafia 3Methane climate change risk suggested by proof of redox cycling of humic substances 2
... Far removed from streams of gas-thirsty cars and pollution-belching ... Circling the northern hemisphere, the conifer-dominated boreal forests ... act as a vast natural regulator of atmospheric carbon ... are studying how environmental factors such as forest fires ...
... MD - The November 1st and November 15th issues of ... online. Topics of interest include voltage-gated potassium channels that ... lipid rafts in cells, and the structure of a Na+/H+ ... 1, 2007 Dynamics of the Kv1.2 voltage-gated ...
... -- Researchers have discovered the secrets to enhancing ... A three-year study entitled "Greener Voices" proves that ... given responsibility for decision making and planning. ... two decades. Gardens are popping up in schools, ...
Cached Biology News:Wildfire drives carbon levels in northern forests 2Media highlights in the November issues of Biophysical Journal 2Media highlights in the November issues of Biophysical Journal 3Children's gardens mushrooming 2
Human peripheral blood PBMCs, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood PBMC and T Cells...
Umbilical cord blood mononuclear cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood MNCs and T Cells...
Umbilical cord blood basophils, For immunohistochemistry (IHC)...
Umbilical cord blood CD4+ T cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood MNCs and T Cells...
Biology Products: